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Novel micelle PCR-based method 
for accurate, sensitive and 
quantitative microbiota profiling
Stefan A. Boers1, John P. Hays1,* & Ruud Jansen2,*
In the last decade, many researchers have embraced 16S rRNA gene sequencing techniques, which 
has led to a wealth of publications and documented differences in the composition of microbial 
communities derived from many different ecosystems. However, comparison between different 
microbiota studies is currently very difficult due to the lack of a standardized 16S rRNA gene sequencing 
protocol. Here we report on a novel approach employing micelle PCR (micPCR) in combination with an 
internal calibrator that allows for standardization of microbiota profiles via their absolute abundances. 
The addition of an internal calibrator allows the researcher to express the resulting operational 
taxonomic units (OTUs) as a measure of 16S rRNA gene copies by correcting the number of sequences 
of each individual OTU in a sample for efficiency differences in the NGS process. Additionally, accurate 
quantification of OTUs obtained from negative extraction control samples allows for the subtraction 
of contaminating bacterial DNA derived from the laboratory environment or chemicals/reagents 
used. Using equimolar synthetic microbial community samples and low biomass clinical samples, we 
demonstrate that the calibrated micPCR/NGS methodology possess a much higher precision and a 
lower limit of detection compared with traditional PCR/NGS, resulting in more accurate microbiota 
profiles suitable for multi-study comparison.
The number of microbiota studies has rapidly increased since the introduction of next-generation sequencing 
(NGS) technologies and opened numerous new fields of research. This research often studies microbiotal changes 
as a result of various kinds of interventions and focusses on changes in the proportional microbial composition 
rather than actual microbial quantities. However, obtaining accurate and quantitative microbiota profiles makes 
high demands on the analytical sensitivity, specificity and reproducibility of standard NGS methodologies and 
requires a careful consideration of potential biases and bacterial DNA contaminations that can be introduced 
during the many steps of sample processing and sequencing1,2.
Recently, the authors published a micelle PCR/NGS (micPCR/NGS) methodology that limits both chimera 
formation and PCR competition, thereby reducing the introduction of PCR amplification biases into microbiota 
profiles3. However, 16S rRNA gene sequencing techniques still remain semi-quantitative methods, where the 
results are presented as proportional abundances of operational taxonomic units (OTUs), rather than absolute 
abundances of OTUs. This restriction lowers the reproducibility of microbiota profiling between different lab-
oratories and does not reveal differences in absolute abundances of specific OTUs. For example, Hiergeist et al. 
observed high inter-laboratory deviations from an external quality assessment of 16S rRNA gene sequencing 
methods and concluded that there is an urgent need to develop microbiota profiling methods with an increased 
cross-study comparability4. This is of particular importance for the increasing implementation of 16S rRNA gene 
sequencing methods in the field of medical diagnostics, which requires high quality demands on the methods 
used. Further, the validity of 16S rRNA gene sequencing results are threatened by the presence of contaminating 
bacterial DNA derived from the laboratory environment and the consumables used in the experimental set-up5. 
Such contamination is particularly relevant for an accurate analysis of microbiota composition of low biomass 
samples (e.g. skin swabs)6,7. These contaminating DNA molecules can be derived from two sources: 1) contami-
nating bacterial DNA present within the sample-processing environment, and 2) contaminating bacterial DNA 
already present in the reagents/consumables used during sample processing. The introduction of contaminating 
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bacterial DNA derived from the processing environment will occur randomly within the samples being processed 
and can be recognized by their non-reproducibility in multiple determinations of the microbiota of a particular 
sample. In contrast, the variety of contaminating bacterial DNA from reagents/consumables will be dependent on 
the manufacturer and batch numbers of the actual reagents/consumables used and will be present in all samples 
processed using these particular reagents/consumables.
In this report, we present a novel approach that employs micPCR/NGS in combination with an internal cali-
brator (IC) to determine the composition and absolute quantity of microbiotal genera. The IC used for this study 
consisted of quantified genomic DNA from a Synechococcus bacterium species that is absent in the natural micro-
bial flora of the samples under investigation and allows the researcher to express the resulting OTUs as a measure 
of 16S rRNA gene copies by the use of a correction factor (sample OTU copies = sample OTU reads x (initial IC 
copies/IC OTU reads)). We utilized this calibrated micPCR/NGS approach to process a range of samples in trip-
licate in order to increase accuracy and to correct for contaminating bacterial DNA derived from the laboratory 
environment. In addition, contaminating bacterial DNA derived from the reagents/consumables used during 
micPCR/NGS were subtracted from samples via the use of a negative extraction control (NEC). To validate the 
calibrated micPCR/NGS approach (including the two-step strategy for removing contaminating bacterial DNA - 
as described above), we used a series of dilutions of an equimolar synthetic microbial community (SMC) sample 
and compared the results obtained against traditional PCR/NGS. Additionally, we evaluated the performance of 
our method to generate accurate quantitative microbiota profiles from actual low biomass clinical samples.
Results
In order to determine the accuracy (trueness and precision) of the calibrated micPCR/NGS methodology, we 
utilized a 10-fold dilution series of a SMC sample containing equimolar 16S rRNA gene copies of Clostridium 
perfringens, Staphylococcus aureus, Haemophilus influenzae, and Moraxella catarrhalis (ranging from 2.5 to 2,500 
16S rRNA gene copies per (mic)PCR of each bacterial species). Prior to amplification, Synechococcus DNA was 
added in such a concentration that each SMC sample contained 10% of IC 16S rRNA gene copies with a mini-
mum of 50 copies for samples that contained less than 500 16S rRNA gene copies. The 16S rRNA gene V3-V4 
regions were amplified in triplicate, using the same SMC/IC sample for each replicate, and sequenced using both 
micPCR/NGS and traditional PCR/NGS (as comparator). As shown in Supplementary Table 1, we obtained an 
average of 4,201 (± 2,398) QC-passed sequence reads per SMC sample using both methods, of which the percent-
age of chimeric sequences was much lower for micPCR/NGS compared to traditional PCR/NGS (0.01% ± 0.03% 
vs. 4.56% ± 2.97%). Further, Table 1 shows the results obtained from triplicate experiments and indicates the 
accuracy for both methodologies used. The micPCR/NGS data, as well as the traditional PCR/NGS data, showed 
a median value of only a 1.3-fold difference between the measured 16S rRNA gene copies (average of triplicate 
experiments) and the expected 16S rRNA gene copies. Although these data suggest a similar and good trueness 
OTU Expected
micPCR/NGS traditional PCR/NGS
Replicate 1 Replicate 2 Replicate 3 Trueness Precision Replicate 1 Replicate 2 Replicate 3 Trueness Precision
Clostridium 2500 6,735 3,840 4,347 2.0 0.3 953 6,638 7,340 2.0 0.7
Staphylococcus 2500 4,776 3,147 4,875 1.7 0.2 403 3,793 4,075 1.1 0.7
Haemophilus 2500 4,082 3,133 2,611 1.3 0.2 370 2,483 2,509 0.7 0.7
Moraxella 2500 3,714 2,213 1,056 0.9 0.6 36 3,034 3,604 0.9 0.9
Clostridium 250 487 631 641 2.3 0.1 736 513 497 2.3 0.2
Staphylococcus 250 486 579 375 1.9 0.2 302 210 284 1.1 0.2
Haemophilus 250 238 225 183 0.9 0.1 281 226 261 1.0 0.1
Moraxella 250 225 363 214 1.1 0.3 240 188 231 0.9 0.1
Clostridium 25 28 31 52 1.5 0.3 119 29 36 2.4 0.8
Staphylococcus 25 57 47 52 2.1 0.1 15 27 50 1.2 0.6
Haemophilus 25 10 9 54 1.0 1.1 112 28 28 2.3 0.9
Moraxella 25 19 5 29 0.7 0.7 116 2 0 1.6 1.7
Clostridium 2,5 0 4 0 0.6 1.6 0 11 1 1.7 1.5
Staphylococcus 2,5 1 15 19 4.6 0.8 243 6 1 33.3 1.7
Haemophilus 2,5 1 0 9 1.3 1.6 0 0 10 1.3 1.7
Moraxella 2,5 1 3 0 0.6 1.1 0 7 0 1.0 1.6
Table 1.  Accuracy of 16S rRNA gene copy determination using synthetic microbial community (SMC) 
samples comparing the results of micPCR/NGS to traditional PCR/NGS. The expected and measured values 
(Replicate 1–3) represent the number of 16S rRNA gene copies obtained for each individual bacterial species 
at four different input DNA concentrations (2,500, 250, 25 and 2.5 16S rRNA gene copies). The trueness shows 
the closeness of measurement results to the true (expected) value and was calculated by dividing the number of 
16S rRNA gene copies measured (as an average of triplicate results) to the expected number of 16S rRNA gene 
copies present in the calibrated synthetic microbial community (SMC). The precision shows the coefficient of 
variation that was calculated by dividing the standard deviation obtained from triplicate results to the average 
number of 16S rRNA gene copies measured.
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among both methods, the dispersal of replicate results varied greatly using traditional PCR/NGS. As shown in 
Fig. 1, the dispersal of replicate results obtained using micPCR/NGS was much smaller than using traditional 
PCR/NGS, indicating the higher precision of the micPCR/NGS methodology. For example, traditional PCR/NGS 
resulted in a coefficient of variation of 0.8, 0.5, 0.9 and 3.0 for the SMC samples containing 2,500, 250, 25 and 2.5 
16S rRNA gene copies per bacterial species, respectively. In contrast, identical experiments using micPCR/NGS 
showed a coefficient of variation of only 0.4, 0.4, 0.6 and 1.4, respectively. The higher precision of the micPCR/
NGS methodology lowers the number of random errors within 16S rRNA gene measurements and increases the 
repeatability of microbiota profiling results (Paired Wilcoxon signed-rank test; p < 0.01). As expected, the accu-
racy for both methods decreases as the number of template DNA molecules decreased due to the limited chance 
of successfully generating 16S rRNA gene amplicons at very low starting concentrations of DNA.
Microbiota analysis is prone to the introduction of contaminating bacterial DNA molecules during sample 
processing. This is illustrated by the finding of 114 distinct OTUs that are represented by at least two or more 
sequence reads in our SMC experiments (Supplementary Tables 2–5). As expected, the number of distinct OTUs 
was maximal in the samples containing low amounts of input DNA, or no input DNA (NEC), leading to an 
unintended overestimation of microbial diversity. To correct for random bacterial DNA contamination from the 
laboratory environment, we processed each sample in triplicate and removed all OTUs that were not present in all 
of the three datasets obtained. To correct for bacterial DNA contamination from the reagents/consumables used, 
we subtracted the contribution of the NEC from each sample. The bacterial DNA contamination from reagents/
consumables was calculated as the mean plus three standard deviations of 16S rRNA gene copies per OTU that 
were present in all three independent NEC measurements (Supplementary Tables 6 and 7). The quantified micro-
biota profiles obtained using micPCR/NGS and traditional PCR/NGS, before and after the correction of contam-
inating bacterial DNA, are shown in Fig. 2. Correcting for both types of bacterial DNA contamination resulted 
in the complete removal of contaminating bacterial DNA from SMC samples generated using the micPCR/NGS 
methodology. In contrast, traditional PCR/NGS results still showed contaminating bacterial DNA present at 25 
and 2.5 16S rRNA gene copies per organism, even after correction. This finding illustrates the higher accuracy of 
the micPCR/NGS methodology to quantify contaminating bacterial DNA from NEC samples and its requirement 
for the accurate subtraction of contaminating bacterial DNA from actual samples. In addition, the traditional 
PCR/NGS methodology failed to recover 25 16S rRNA gene copies of M. catarrhalis and hugely overestimated 
the abundance of S. aureus 16S rRNA gene copies in the SMC samples containing 2.5 16S rRNA gene copies per 
bacterium. Additionally, micPCR/NGS successfully detected all four bacterial species at 2,500, 250 and 25 16S 
rRNA gene molecules per bacterium, but failed to detect any of these species in triplicate experiments using 2.5 
16S rRNA gene copies. We therefore estimated that the analytical sensitivity, indicated as the limit of detection 
(LOD), for micPCR/NGS is 25 16S rRNA gene molecules per OTU, whereas the LOD of traditional PCR/NGS 
was estimated as 250 16S rRNA gene copies per OTU.
In order to investigate the performance of the calibrated micPCR/NGS protocol using clinical samples, we 
selected four human skin swab samples that contained a low number of 16S rRNA gene copies (range: 64–604 
16S rRNA gene copies/μ L). The four samples, including an NEC, were processed in triplicate using micPCR/NGS 
and traditional PCR/NGS in parallel. Using micPCR/NGS, we obtained an average of 7,126 (± 1,702) QC-passed 
sequence reads per sample, of which only 2 (± 3) sequences per sample were identified and removed as chi-
meric sequences (Supplementary Table 8). Next, we were able to detect 3 to 13 OTUs in the samples, of which 
Figure 1. Precision of 16S rRNA gene copy determination using synthetic microbial community samples 
comparing the results of micPCR/NGS to traditional PCR/NGS. The synthetic microbial community (SMC) 
samples tested contained equimolar 16S rRNA gene copy numbers derived from four different bacterial species 
and ranged from 2,500 to 2.5 16S rRNA gene copies per species. Colored data points represent the individual 
measurements per bacterial OTU from triplicate experiments, corrected for the number of expected 16S rRNA 
gene copies and plotted using a binary logarithmic scale.
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Staphylococcus and Neisseria species were commonly found and could be confirmed by bacterial culture. In 
addition, the micPCR/NGS method also detected the skin inhabitants Streptococcus, Paracoccus, Enhydrobacter, 
Gemella, Sphingomonas, Alloprevotella, Propionibacterium, Brevundimonas, Roseomonas, Rothia, Granulicatella, 
Rhodococcus, and Flavobacteriaceae species8,9. Importantly, correcting for contaminating bacterial DNA using 
the two-step strategy as described above removed 92% (range 89 − 96%) of the resultant OTUs found in the 
skin swab samples (Supplementary Table 9). Finally, we measured a high concordance between the total bacte-
rial biomass when estimated indirectly using calibrated micPCR/NGS, without the correction for contaminating 
bacterial DNA, compared to the total 16S rRNA gene copies obtained when estimated directly using a 16S rRNA 
gene qPCR according to Yang et al.10, with an average of only a 1.03-fold difference (± 0.34), demonstrating the 
accuracy of the micPCR/NGS method. In contrast to micPCR/NGS, traditional PCR/NGS was not able to gen-
erate any 16S rRNA gene amplicons from these low biomass skin swab samples as this method only generated 
non-specific, low molecular weight amplicons. These non-specific PCR products were most like generated by 
the relative excess of human DNA - compared to bacterial DNA - in the samples, as the PCR/NGS methodology 
successfully generated 16S rRNA gene amplicons in SMC samples (where only bacterial DNA and no human 
DNA was present). This result indicates that the LOD for the traditional PCR/NGS methodology is even higher 
for actual clinical samples than was previously estimated using our SMC samples.
Discussion
In this report we show that a micelle PCR/NGS methodology (micPCR/NGS), in combination with a unique 
internal calibrator (IC) generates robust and accurate quantitative microbiota profiles. Micelle PCR is charac-
terized by the clonal amplification of template DNA by the physical separation of reaction ingredients into a 
Figure 2. 16S rRNA gene microbiota profiles obtained from synthetic microbial community samples 
comparing the results of micPCR/NGS to traditional PCR/NGS before and after correction for 
contaminating bacterial DNA. The synthetic microbial community (SMC) samples tested comprised 
equimolar 16S rRNA gene copies derived from C. perfringens, S. aureus, H. influenzae, and M. catarrhalis 
and ranging from 2,500 to 2.5 16S rRNA gene copies per bacterial species. Averages of triplicate micPCR/
NGS and triplicate traditional PCR/NGS results are shown in 100% stacked bars before and after correction 
for contaminating bacterial DNA. The correction of contaminating bacterial DNA comprises two steps: 1) 
eliminating OTUs that could not be reproducibly measured in triplicate experiments, and 2) subtracting 16S 
rRNA gene copies that were also quantified in triplicate measurements of a negative extraction control (NEC) 
sample. Values within bars represent the calculated number of 16S rRNA gene copies per bacterial OTU.
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large number of reaction compartments. In contrast to traditional PCR, which is performed in a single reaction 
volume, the compartmentalization during micPCR allows accurate quantification of target sequences due to a 
lower susceptibility to variations in PCR amplicon efficiencies and amplification biases such as chimera forma-
tion, false priming and primer dimer formation3. Therefore, our calibrated micPCR/NGS method allows for the 
utilization of just a single correction factor, obtained from a single IC, to convert 16S rRNA gene sequence reads 
to 16S rRNA gene copies for each individual OTU present within a sample. In contrast, optimized traditional PCR 
amplification protocols11 or alternative spike-in approaches that employ traditional PCR amplification methods, 
such as SCML12, remain vulnerable to template-specific variations in PCR efficiencies that could easily result in 
error-derived microbiota profiles. However, it is true that the number of 16S rRNA gene copies produced using 
micPCR depends on the actual volume of individual micelles and that possible quantitation biases might be 
introduced due to differences in micelle sizes. This may be particularly relevant for the accurate quantification of 
low abundant taxa that are more vulnerable to the possible stochastic distribution of template DNA molecules 
into unevenly shaped micelles. However, the randomness of micelle size frequency distributions generated in 
independent experiments will tend to average out any possible quantification bias generated due to differences in 
the distribution of micelle sizes between independent experiments, as indicated by the results obtained using our 
synthetic microbial community (SMC).
The absolute quantification of OTUs using micPCR/NGS in combination with an internal calibrator improves 
the standardization of microbiota profiling results by removing the susceptibility to compositional effects. For 
example, traditional 16S rRNA gene sequencing methods require specific tools and methods that properly 
account for the statistical implications from the compositional structure of the data obtained13. But despite the 
growing interest and recent efforts to develop these sophisticated methods, the problems of spurious correla-
tions in compositional data remain as yet unsolved14. In contrast, our results show that the use of the calibrated 
micPCR/NGS strategy greatly improves standardization of microbiota research without the reliance on (complex) 
compositional data analysis. However, these results remain vulnerable to contaminating bacterial DNA molecules 
derived from the sample processing environment. In order to correct for contaminating bacterial DNA, we elim-
inated OTUs that could not be reproducibly measured in triplicate experiments and subtracted 16S rRNA gene 
copies that were also quantified from negative extraction control (NEC) samples. The comparison of the micPCR/
NGS and traditional PCR/NGS results showed that both methods possess a similar trueness when profiling the 
microbiota of synthetic microbial community (SMC) samples. However, the precision of the micPCR/NGS was 
much higher compared to the traditional PCR/NGS method. The low precision of the traditional PCR/NGS 
methodology resulted in unpredictable random errors within the microbiota profiles obtained, including those 
obtained from NEC samples. The increased random errors observed using traditional PCR/NGS makes the accu-
rate subtraction of bacterial DNA contamination unreliable, whilst in contrast, the high precision of micPCR/
NGS resulted in highly accurate quantification of (contaminating) 16S rRNA gene copies resulting in improved 
quantitative microbiota profiles that were free of contaminating bacterial DNA from environmental sources.
Using micPCR/NGS, we determined the quantitative microbiota profiles of low biomass skin swab samples. As 
expected, most OTUs (> 89%) obtained from these clinical samples could not be reliably determined in triplicate, or 
the quantified number of 16S rRNA gene copies did not exceed the quantified number of the same 16S rRNA gene 
copies determined within NEC samples, and were removed accordingly. This finding stresses the importance of 
removing contaminating bacterial DNA from microbiota profiles obtained using low biomass samples. Additionally, 
traditional PCR/NGS was not able to generate any useful 16S rRNA gene sequencing data using the same clinical 
samples. This result is probably caused by other sample components than bacterial DNA, such as human DNA, that 
interferes with traditional PCR reactions (via inhibition or competition). This finding also illustrates the specific 
nature of PCR in micelles. Since all sample components (both 16S rRNA gene templates and non-templates) are lim-
ited to a single micelle, micPCR reactions are not affected by inhibiting or competing components and are still able 
to generate 16S rRNA gene amplicons successfully. However, it is important to note that possible effects of sample 
storage conditions15, cell lysis16, and primer specificity17 on the final results of these microbiota profiles still exist.
In summary, a combination of micPCR/NGS and an internal calibrator generates robust and accurate quan-
titative microbiota profiles. The high accuracy and low limit of detection of the calibrated micPCR/NGS, makes 
this method the preferential method to determine accurate and quantitative microbiota profiles for low biomass 
samples that are hampered by contaminating bacterial DNA. The general adoption of this approach by microbiota 
investigators will greatly improve the standardization of microbiota profiling results between individual experi-
ments, laboratories and scientific publications.
Methods
Synthetic microbial community samples. The DNA used to create the SMC samples was extracted from 
four independently cultured bacterial strains; Moraxella catarrhalis (ATCC 25240), Staphylococcus aureus (ATCC 
43300), Haemophilus influenzae (ATCC 10211), and Clostridium perfringens (ATCC 12915), using a phenol/
bead-beating protocol combined with the AGOWA mag Mini DNA Isolation Kit (LGC) as described previously6. 
In addition, DNA from elution buffer BL (LGC) was extracted as a negative extraction control (NEC) sample at the 
same time to assess the composition of contaminating bacterial DNA in the experimental methodologies. In order 
to generate an equimolar mixture of 16S rRNA gene targets from the four bacterial DNA extracts, and to normalize 
the Synechococcus sp. (ATCC® 27264D-5) DNA used as IC, the total dsDNA concentration from each DNA isolate 
was determined individually using the Quant-iT PicoGreen dsDNS assay Kit (Life Technologies) and normalized 
for genome sizes and 16S rRNA gene copy numbers based on bacterial whole-genome sequences that are publically 
available at the NCBI database. Next, a 10-fold dilution series of the equimolar SMC sample was made, ranging 
from 2,500 to 2.5 16S rRNA gene copies per organism. Prior to amplification by either micPCR or traditional PCR, 
1,000, 100, 100, 50 and 50 16S rRNA gene copies of Synechococcus DNA was added as IC to the SMC DNA extracts 
containing 2,500, 250, 25, 2.5 16S rRNA gene copies per bacterial species and the NEC DNA extract, respectively.
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Skin swab samples. An acknowledged national ethics committee from the Netherlands (Medisch Ethische 
Toetsingscommissie Noord-Holland, http://www.metc.nl) approved the study protocol (M015–021) and all 
experiments were performed in accordance with the relevant guidelines and regulations. Skin swab samples were 
collected from patients with atopic dermatitis after written, informed consent was obtained from all subjects. 
Skin swab samples were collected using E-swabs (490CE, Copan) by gently rubbing the dry flocked swab over the 
dermatitis lesion (~2 cm2) for 10 seconds after which the entire sample was eluted upon contact with 1 mL liquid 
Amies preservation medium. All samples were cultured according to standard laboratory protocols performed 
in our laboratory and stored at − 80 °C for subsequent 16S rRNA gene sequencing analysis. The routine culture 
methods included aerobic overnight culture at 35 degrees Celsius on CAP, TSASB and CLED agar plates after 
which Matrix-Assisted Laser Desorption Ionization Time-Of-Flight (MALDI-TOF) mass spectrometry was used 
for the identification of cultured bacterial species. For 16S rRNA gene sequencing analysis, DNA was extracted 
from the skin swab samples using the High Pure PCR Template Preparation Kit (Roche) according to the manu-
facturer’s instructions. In addition, DNA from Amies medium (490CE, Copan) was extracted as an NEC sample 
at the same time to allow contaminating bacterial DNA subtraction after NGS processing. Note that in this study 
we did not focus on DNA extraction efficiencies and the DNA extraction kit used may not be 100% efficient 
for determining microbial communities from skin swab samples. The total number of 16S rRNA gene copies 
within each DNA extract was measured using a 16S quantitative PCR (qPCR) according to Yang et al.10. For this, 
CT-values were related to a serial dilution of the previously calibrated and normalized SMC sample and ranged 
from a total of 100 to 10,000 16S rRNA gene copies per PCR reaction. Prior to amplification by either micPCR or 
traditional PCR, 50 16S rRNA gene copies of Synechococcus DNA was added as IC to the skin swab DNA extracts 
and the NEC DNA extract.
Micelle PCR and traditional PCR amplification. 16S rRNA gene amplicon library preparation using 
micPCR and traditional PCR was performed as previously published3, but with a slight modification. 
In this study, both amplification strategies were performed using modified 341F (5′ -GACACTAT 
AGCCTACGGGRSGCAGCAG-3′ ) and 806R (CACTATAGGGACTACNVGGGTWTCTAAT) primers that 
amplified the V3-V4 regions of 16S rRNA genes and which incorporated universal sequence tails at their 5′ ends 
to allow for a two-step amplification strategy. Also, both micPCR and traditional PCR were performed using the 
same PCR reagents (except for the oil phase used to generate the micelles) and PCR conditions following the 
Micelle PCR Amplification protocol as previously published3. Finally, both micPCR/NGS and the traditional 
PCR/NGS methodology utilized the same amplicon purification steps to synchronize experimental conditions.
16S rRNA gene sequencing and data analysis. Bidirectional sequencing of the 16S rRNA gene 
amplicon libraries was performed using the 454 Genome Sequencer (GS) Junior platform (Roche), with 
Fasta-formatted sequences being extracted from the GS Junior machine and further processed using the mothur 
v. 1.33.0 software package18. Primer sequences were trimmed and sequences that had an ambiguous base call (N) 
in the sequence or with lengths smaller than 400 were removed from the analysis. Unique sequences were then 
aligned against a customized reference alignment based on the SILVA reference alignment release 119 (availa-
ble at: http://www.mothur.org/wiki/Silva_reference_alignment). The reference sequences were trimmed to only 
include the V3-V4 region of the 16S rRNA gene using the pcr.seqs command. Sequences that did not align to this 
region were culled from further analysis and the alignments were trimmed so that the sequences fully overlapped 
the same alignment coordinates. Potentially chimeric sequences were removed using Uchime, as implemented 
in mothur. The remaining sequences were classified using the classify.seqs command with the customized SILVA 
alignment release 119 as reference. Next, sequences were clustered into OTUs at 97% similarity using the default 
settings of the dist.seq and cluster commands respectively. The classify.otu algorithm was used to get a consensus 
taxonomy for each OTU. Finally, all SMC samples were rarefied to 1,000 sequences per sample and all skin swab 
samples were rarefied to 5,000 sequences per sample. The sequencing data that are connected to this article are 
uploaded to the Sequence Read Archive database with accession number SRP076831.
Statistical analyses. The Kolmogorov-Smirnov test was used to check the normality of data distribution. 
Precision analyses were performed by calculating the coefficient of variation for each of the four OTUs obtained 
from the SMC samples. The paired Wilcoxon signed-rank test was used to compare the coefficients of variation 
obtained using micPCR/NGS and traditional PCR/NGS (SPSS version 23, IBM Corporation).
References
1. Boers, S. A., Jansen, R. & Hays, J. P. Suddenly everyone is a microbiota specialist! Clin Microbiol. Infect. 22, 581–582 (2016).
2. Brooks, J. P. et al. The truth about metagenomics: quantifying and counteracting bias in 16S rRNA studies. BMC Microbiol. 15, 66 
(2015).
3. Boers, S. A., Hays, J. P. & Jansen, R. Micelle PCR reduces chimera formation in 16S rRNA profiling of complex microbial DNA 
mixtures. Sci. Rep. 5, 14181 (2015).
4. Hiergeist, A. & Reischl, U. Priority Program Intestinal Microbiota Consortium/quality assessment participants & Gessner, A. 
Multicenter quality assessment of 16S ribosomal DNA-sequencing for microbiome analyses reveals high inter-center variability. Int. 
J. Med. Microbiol. 306, 334–342 (2016).
5. Salter, S. J. et al. Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol. 12, 87 
(2014).
6. Biesbroek, G. et al. Deep sequencing analyses of low density microbial communities: working at the boundary of accurate microbiota 
detection. PloS one 7, e32942 (2012).
7. Meisel, J. S. et al. Skin microbiome surveys are strongly influenced by experimental design. J. Invest. Dermatol. 136, 947–956 (2016).
8. Gao, Z., Tseng, C. H., Pei, Z. & Blaser, M. J. Molecular analysis of human forearm superficial skin bacterial biota. Proc. Natl. Acad. 
Sci. USA 104, 2927–2932 (2007).
www.nature.com/scientificreports/
7Scientific RepoRts | 7:45536 | DOI: 10.1038/srep45536
9. van Rensburg, J. J. et al. The human skin microbiome associates with the outcome of and is influenced by bacterial infection. MBio 
6, e01315–01315 (2015).
10. Yang, S. et al. Quantitative multiprobe PCR assay for simultaneous detection and identification to species level of bacterial 
pathogens. J. Clin. Microbiol. 40, 3449–3454 (2002).
11. Gohl, D. M. et al. Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies. Nat. 
Biotechnol. 34, 942–949 (2016).
12. Stammler, F. et al. Adjusting microbiome profiles for differences in microbial load by spike-in bacteria. Microbiome 4, 28 (2016).
13. McMurdie, P. J. & Holmes, S. Waste not, want not: why rarefying microbiome data is inadmissible. PLoS Comput. Biol. 10, e1003531 
(2014).
14. Tsilimigras, M. C. & Fodor, A. A. Compositional data analysis of the microbiome: fundamentals, tools, and challenges. Ann. 
Epidemiol. 26, 330–335 (2016).
15. Cardona, S. et al. Storage conditions of intestinal microbiota matter in metagenomic analysis. BMC Microbiol. 12, 158 (2012).
16. Kennedy, N. A. et al. The impact of different DNA extraction kits and laboratories upon the assessment of human gut microbiota 
composition by 16S rRNA gene sequencing. PloS one 9, e88982 (2014).
17. Mao, D. P., Zhou, Q., Chen, C. Y. & Quan, Z. X. Coverage evaluation of universal bacterial primers using the metagenomic datasets. 
BMC Microbiol. 12, 66 (2012).
18. Schloss, P. D. et al. Introducing mothur: open-source, platform-independent, community-supported software for describing and 
comparing microbial communities. Appl. Environ. Microbiol. 75, 7537–7541 (2009).
Acknowledgements
We would like to thank Sjoerd M. Euser, PhD and Wil A. van der Reijden, PhD for their help with the statistical 
analysis. We are also thankful to Bjorn L. Herpers, MD, PhD for organizing the collection of skin swab samples 
included in this study and Paul Badoux for characterizing the bacterial communities of these samples using 
bacterial culture. This work has received funding from the European Union’s Seventh Framework Programme for 
Health under grant agreement number 602860 (TAILORED-Treatment; www.tailored-treatment.eu).
Author Contributions
Conceived and designed the experiments: S.B., J.H., and R.J. Performed the experiments: S.B. Analyzed the data: 
S.B. Wrote the paper: S.B., J.H., and R.J. All authors read and approved the final manuscript.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing Interests: The authors declare no competing financial interests.
How to cite this article: Boers, S. A. et al. Novel micelle PCR-based method for accurate, sensitive and 
quantitative microbiota profiling. Sci. Rep. 7, 45536; doi: 10.1038/srep45536 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2017
